Clinical Trials In Latin America
•
17 likes•5,522 views
Clinical trials in Latin America face regulatory frameworks that vary by country. While countries like Argentina, Brazil, and Mexico have adopted international good clinical practice guidelines, regulatory approval processes can be lengthy, requiring documents translated to the local language and approvals from both local and national ethics boards. Common challenges include economic instability, intellectual property protection, and health care access and costs. Strategies for successful clinical trials in the region include early planning, partnering with experienced local clinical research organizations, and consulting regulatory experts from within each country.
![Clinical Trials in Latin America Pharmaceutical Market & Regulatory Framework ,[object Object],[object Object],[object Object],[object Object]](https://image.slidesharecdn.com/LEWISJulianeClinicalTrialsinLatinAmericaJHU2008-12305560073-phpapp02/85/Clinical-Trials-In-Latin-America-1-320.jpg)
![Latin America introduction ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Recommended
More Related Content
What's hot
What's hot (20)
Viewers also liked
Viewers also liked (12)
Similar to Clinical Trials In Latin America
Similar to Clinical Trials In Latin America (20)
Recently uploaded
Recently uploaded (19)
Clinical Trials In Latin America
- 11. Juliane Lewis [email_address] Gracias Thank you Obrigada
Editor's Notes
- SPEECH NOTES: Hello and welcome. This presentation will briefly discuss the current pharmaceutical market and regulatory framework for clinical trials in Latin America. You will become familiar with the most current legal framework and challenges related to the conduct of clinical trials in the region, with emphasis in the top three markets: Brazil, Argentina and Mexico. References for local regulatory authorities will be provided. Strategies that will help international companies plan implementation of trials as part of global drug development strategy is discussed at the end.